Drug Target Review – Issue 1 2019

Posted: 14 March 2019 | | No comments yet

In this issue: AI-driven automated chemistry as a tool to accelerate drug discovery processes, the shifting landscape of immuno-oncology, and how lipid molecules provide an insight into biological research.

Drug Target Review issue 1 2019 magazine

Included in this issue:

    Cell line development – global market drivers, trends and its impact on improving biologics development from early phase to IND during the drug discovery process
    Aparajita Dubey, Associate Consultant at Prescient Healthcare Group
    The importance of characterising chemical starting points of drugs using appropriate in vitro ADME-toxicity assays
    Massimiliano Runfola, University of Pisa and Sheraz Gul,
    Fraunhofer IME
    Kick-starting the immune response – the shifting landscape of immuno-oncology
    Nathan Robertson, Oxford Genetics
    Drug discovery from the age of informationto the age of intelligence
    Jeff Martin, Head of Compound Management, Alkermes, Inc.
    Farther than fat: how lipids change research
    Dr Christian Klose, Head of Research & Development at Lipotype GmbH
    Network-driven drug discovery
    Jonny Wray and Alan Whitmore, e-therapeutics plc.


This issue is restricted - login or subscribe free to access

DTR Issue 3 2021 MiniMagThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • quarterly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here